Table 1 Baseline Characteristics
From: The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS
Cohort (n = 182) | |
|---|---|
Age, years | 66 ± 8 |
Male sex | 112 (62%) |
White race | 153 (84%) |
FEV1, percent predicted | 68 ± 21 |
FVC, percent predicted | 94 ± 19 |
FEV1/FVC | 0.54 ± 0.11 |
GOLD Stage | |
GOLD 1 GOLD 2 GOLD 3 GOLD 4 | 48 (26.4%) 88 (48.4%) 44 (24.2%) 2 (1.0%) |
Current Smoker | 70 (39%) |
Pack-year history | 51 ± 21 |
CAT | 14 ± 8 |
SGRQ score, total | 33 ± 19 |
CB-SGRQ | 101/173 (56%) |
MMRC dyspnea score | 1 [0–1] |
6-min walk distance, m | 412 ± 101 |
PRM-emph (%) | 7.3 ± 10.4 |
PRM-fSAD (%) | 23.4 ± 11.7 |
Severe AECOPD in the previous year | 18/175 (10%) |
Plasma AcPGP ng/ml | 0.60 ± 1.13 |
Sputum AcPGP ng/ml | 0.61 ± 1.89 |